8-K
Current Report
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-19-074602
Shareholder rights changed · Bylaws or fiscal year change
- Item 3.03 Material modification to rights of security holders
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading tm1926620d1_8k.htm…